FDA Inspection 1266823 — Lanzhou Foci Pharmaceutical Co., Ltd.
The FDA completed an inspection of Lanzhou Foci Pharmaceutical Co., Ltd. on Mar 20, 2025 in Lanzhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 20, 2025
- Fiscal Year
- 2025
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Lanzhou (China)